All Stories

  1. Complete genome sequence of an Indian outbreak strain of chikungunya virus
  2. Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses
  3. Protein Nanoparticles as Viral Vaccine Platforms
  4. A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge
  5. Redox Regulation and Metabolic Dependency of Zika Virus Replication: Inhibition by Nrf2-Antioxidant Response and NAD(H) Antimetabolites
  6. Dose–Response Effects of 7-Dehydrocholesterol Reductase Inhibitors on Sterol Profiles and Vesicular Stomatitis Virus Replication
  7. Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
  8. Palmitoleate Protects against Zika Virus-Induced Placental Trophoblast Apoptosis
  9. Inhibition of Zika virus replication by G-quadruplex-binding ligands
  10. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication
  11. Current Status of Zika Virus Vaccines: Successes and Challenges
  12. Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners
  13. An Attenuated Zika Virus Encoding Non-Glycosylated Envelope (E) and Non-Structural Protein 1 (NS1) Confers Complete Protection against Lethal Challenge in a Mouse Model
  14. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening
  15. Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion
  16. Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2–4 to the induction of protective immunity
  17. Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus
  18. Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection
  19. Identification of viral genes associated with the interferon-inducing phenotype of a synthetic porcine reproductive and respiratory syndrome virus strain
  20. Trim21 regulates Nmi-IFI35 complex-mediated inhibition of innate antiviral response
  21. A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection
  22. Mutations in the 5’ NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity
  23. FRONT MATTER
  24. BACK MATTER
  25. OVERVIEW OF RHABDO- AND FILOVIRUSES
  26. HOST CELL FUNCTIONS IN VESICULAR STOMATITIS VIRUS REPLICATION
  27. Biology and Pathogenesis of Rhabdo- and Filoviruses
  28. Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5
  29. IFI35 downregulates IFN signaling and supports VSV replication
  30. Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus
  31. Heterogeneous Nuclear Ribonucleoprotein K Supports Vesicular Stomatitis Virus Replication by Regulating Cell Survival and Cellular Gene Expression
  32. Manipulation of Cellular Processing Bodies and Their Constituents by Viruses
  33. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes
  34. Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1
  35. Induction of Stress Granule-Like Structures in Vesicular Stomatitis Virus-Infected Cells
  36. Amino acid residues in the non-structural protein 1 of porcine reproductive and respiratory syndrome virus involved in down-regulation of TNF-α expression in vitro and attenuation in vivo
  37. A single amino acid change resulting in loss of fluorescence of eGFP in a viral fusion protein confers fitness and growth advantage to the recombinant vesicular stomatitis virus
  38. Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus
  39. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice
  40. Glycosyl-phosphatidylinositol (GPI)-anchored membrane association of the porcine reproductive and respiratory syndrome virus GP4 glycoprotein and its co-localization with CD163 in lipid rafts
  41. Posttranslational Modification of Vesicular Stomatitis Virus Glycoprotein, but Not JNK Inhibition, Is the Antiviral Mechanism of SP600125
  42. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses
  43. Cellular Poly(C) Binding Proteins 1 and 2 Interact with Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1  and Support Viral Replication
  44. Transcription of Vesicular Stomatitis Virus RNA Genome
  45. Antagonistic Effects of Cellular Poly(C) Binding Proteins on Vesicular Stomatitis Virus Gene Expression
  46. Immune Evasion of Porcine Reproductive and Respiratory Syndrome Virus through Glycan Shielding Involves both Glycoprotein 5 as Well as Glycoprotein 3
  47. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response
  48. A virulent strain of porcine reproductive and respiratory syndrome virus does not up-regulate interleukin-10 levels in vitro or in vivo
  49. Porcine reproductive and respiratory syndrome virus non-structural protein 1 suppresses tumor necrosis factor-alpha promoter activation by inhibiting NF-κB and Sp1
  50. Induction of Interferon and Interferon Signaling Pathways by Replication of Defective Interfering Particle RNA in Cells Constitutively Expressing Vesicular Stomatitis Virus Replication Proteins
  51. Biarsenical Labeling of Tetracysteine-Tagged Proteins for Tracking Existing and Newly Synthesized Pools of Proteins
  52. The Minor Envelope Glycoproteins GP2a and GP4 of Porcine Reproductive and Respiratory Syndrome Virus Interact with the Receptor CD163
  53. Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1β Modulates Host Innate Immune Response by Antagonizing IRF3 Activation
  54. GP3 is a structural component of the PRRSV type II (US) virion
  55. Single-Amino-Acid Alterations in a Highly Conserved Central Region of Vesicular Stomatitis Virus N Protein Differentially Affect the Viral Nucleocapsid Template Functions
  56. Transfection of porcine sialoadhesin into a murine macrophage cell-line renders it permissive for PRRSV replication
  57. Biarsenical Labeling of Vesicular Stomatitis Virus Encoding Tetracysteine-Tagged M Protein Allows Dynamic Imaging of M Protein and Virus Uncoating in Infected Cells
  58. The ESCRT-I Subunit TSG101 Controls Endosome-to-Cytosol Release of Viral RNA
  59. Identification of virulence determinants of porcine reproductive and respiratory syndrome virus through construction of chimeric clones
  60. A model for the dynamic nuclear/nucleolar/cytoplasmic trafficking of the porcine reproductive and respiratory syndrome virus (PRRSV) nucleocapsid protein based on live cell imaging
  61. Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes
  62. Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 Expression
  63. Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model
  64. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus
  65. Visualization of Intracellular Transport of Vesicular Stomatitis Virus Nucleocapsids in Living Cells
  66. Influence of N-Linked Glycosylation of Porcine Reproductive and Respiratory Syndrome Virus GP5 on Virus Infectivity, Antigenicity, and Ability To Induce Neutralizing Antibodies
  67. Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication
  68. Construction of a Full-Length cDNA Infectious Clone of a European-Like Type 1 PRRSV Isolated in the U.S.
  69. Role of the Hypervariable Hinge Region of Phosphoprotein P of Vesicular Stomatitis Virus in Viral RNA Synthesis and Assembly of Infectious Virus Particles
  70. The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes
  71. A highly pathogenic porcine reproductive and respiratory syndrome virus generated from an infectious cDNA clone retains the in vivo virulence and transmissibility properties of the parental virus
  72. Phosphorylation of Vesicular Stomatitis Virus Phosphoprotein P Is Indispensable for Virus Growth
  73. Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral Infection
  74. Basic Amino Acid Residues at the Carboxy-Terminal Eleven Amino Acid Region of the Phosphoprotein (P) Are Required for Transcription but Not for Replication of Vesicular Stomatitis Virus Genome RNA
  75. Replication Signals in the Genome of Vesicular Stomatitis Virus and Its Defective Interfering Particles: Identification of a Sequence Element That Enhances DI RNA Replication
  76. The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles
  77. Infectious defective interfering particles of VSV from transcripts of a cDNA clone
  78. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
  79. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system
  80. Identification of the defects in the hemagglutinin gene of two temperature-sensitive mutants of A/WSN/33 influenza virus
  81. THE S SEGMENT OF BUNYAVIRUSES CODES FOR TWO COMPLEMENTARY RNAs
  82. Identification of four complementary RNA species in Akabane virus-infected cells
  83. Early RNA Synthesis in Bunyamwera Virus-infected Cells